Lobbying Relationship

Client

Pfizer, Inc.

More records

Lobbying firm

DLA Piper LLP (US)

More records

  • Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; prescription drug abuse.
  • Issues related to Medicare/Medicaid reimbursements.

Duration: to

General Issues: Health Issues, Medicare/Medicaid

Spending: about $420,000 (But it's complicated. Here's why.)

Agencies lobbied since 2011: U.S. Senate, House of Representatives, Executive Office of the President (EOP)

Bills mentioned

S.1228: Medicare Better Health Rewards Program Act of 2013

Sponsor: Ron Wyden (D-Ore.)

H.R.2725: Food and Drug Administration Safety Over Sequestration Act of 2013

Sponsor: Leonard Lance (R-N.J.)

S.3187: Food and Drug Administration Safety and Innovation Act

Sponsor: Tom Harkin (D-Iowa)

H.R.5651: Food and Drug Administration Reform Act of 2012

Sponsor: Fred Upton (R-Mich.)

H.R.3668: Counterfeit Drug Penalty Enhancement Act of 2012

Sponsor: Pat Meehan (R-Pa.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Mary Langowski Legis Aide, Sen. Tom Harkin; Senate Agriculture Committee
Piper Nieters Su Legislative Counsel, Sen. Ken Salazar
Steven Phillips Legislative Director, Sen. Jesse Helms
Krista Drobac Schedule C, Centers for Medicaid/Medicare Srvs; Legis Asst, Sen. Durbin; Fellow, Sen. Stabenow Schedule C, Centers for Medicaid/Medicar Srvs.; Legis. Asst. for Sen. Durbin; Fellow, Sen. Stabenow
John Slotman LA/LD Rep Emerson; LA Rep Shuster; W&M Staff
James Miller Deputy Asst Secy for Tax Policy, Dept of Treasury
Timothy Hogan LA, Sen. Daschle; Staff, Senate Finance Committee
Evan Migdail n/a
Nicole Carelli n/a
Ilia Rodriguez n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page